February 2022 Vol 12, No 1

ASH Highlights

Meeting Highlights

ASH Highlights

Mosunetuzumab, a Bispecific Antibody, Induces Deep Remissions in Relapsed or Refractory Follicular Lymphoma

Meeting Highlights

ASH Highlights, Venetoclax

Time-Limited Venetoclax Combinations Superior to Chemoimmunotherapy in Fit Patients with CLL

Meeting Highlights

ASH Highlights

Isatuximab plus RVd Regimen Achieves Highest Rates of No MRD in Patients with Multiple Myeloma

Meeting Highlights

ASH Highlights

Ivosidenib Added to First-Line Azacitidine Improves Outcomes in Older Patients with AML

Meeting Highlights

ASH Highlights

Polatuzumab Vedotin plus R-CHP Outperforms R-CHOP as First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

Meeting Highlights

ASH Highlights

A Paradigm Shift: CAR T-Cell Therapy Beats Standard of Care as Second-Line Treatment for Large B-Cell Lymphoma

Meeting Highlights

ASH Highlights

Immune Responses to COVID-19 Vaccines Low Among Patients with Hematologic Malignancies, but mRNA Vaccines Induce Strong Antibody Response in AML and MDS

Peer Reviewers

Peer Reviewers

Thank You JHOP Peer Reviewers

Case Reports

Case Reports, Leukemia, Adverse Events

Dasatinib-Induced Gynecomastia in 2 Patients with Chronic Myeloid Leukemia: Case Reports and Review of the Literature

Jessie Signorelli, PharmD, BCOP; Amir T. Fathi, MD; Gabriela Hobbs, MD

Case Reports, Breast Cancer, Adverse Events

Spontaneous Tumor Lysis Syndrome in a Patient with Stage IV HER2-Positive Breast Cancer: Case Report

Blake T. Robbins, PharmD, MBA; Alexander M. Kreimer, PharmD, BCPS; Reema A. Patel, MD; Allison R. Butts, PharmD, BCOP

Original Research

Original Research, Chemotherapy, Practical Issues in Pharmacy Management

Evaluation of the Safety and Potential Time-Savings of Subcutaneous Rituximab Administration in a Single Cancer Center

Ashka Patel, PharmD, BCOP; Chirag Patel, MS; Caroline M. Mejías-De Jesús, PharmD, BCOP

Original Research, Pediatric Cancer, Leukemia, Lymphoma

Lidocaine plus Tetracaine–Medicated Patch Used for Propofol Sedation During Lumbar Punctures in Pediatric Patients with Blood Cancer

Lisa R. Garavaglia, PharmD; Frank Casey, MD; Lesley Cottrell, PhD; Claudiu Faraon-Pogaceanu, MD; Stephan Paul, MD; Melvin Lee Wright, DO

Review Article

Review Article, CAR T-Cell Therapy, Lymphoma

A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas

Drew A. Wells, PharmD, BCPS; Jenna Summerlin, PharmD; Zachery Halford, PharmD, BCOP, BCPPS

FDA Updates

FDA Updates

Enobosarm Granted Fast-Track FDA Review for AR- and ER-Positive, HER2-Negative Metastatic Breast Cancer

FDA Updates

FDA Grants Gedatolisib, a Dual PI3K and mTOR Inhibitor, Fast-Track Review for ER-Positive, HER2-Negative Breast Cancer

FDA Updates

Rituximab plus Chemotherapy FDA Approved for Several Pediatric Hematologic Malignancies

FDA Updates

Keytruda Now Approved for the Adjuvant Treatment of Stage IIB/IIC Melanoma

FDA Updates

Orencia First Drug FDA Approved for the Prevention of Acute Graft-versus-Host Disease

FDA Updates

Kimmtrak, a Bispecific CD3 T-Cell Engager, First FDA-Approved Drug for Unresectable or Metastatic Uveal Melanoma

JHOP - February 2022 Vol 12, No 1

Subscribe Today!

I'd like to receive:

JHOP - February 2022 Vol 12, No 1

Subscribe Today!

I'd like to receive:

We Value Your Feedback! Tell Us How You Consume Content